touchPODCAST touchpodcast

touchMDT for touchENDOCRINOLOGY
Listen to experts Prof. Karin Blakemore, Prof. Klaus Mohnike, Prof. Janet Legare and patient advocate Carly Kutner provide their insights on the impact of pharmacotherapies for achondroplasia
The multidisciplinary team and patient advocate:
MFM specialist - Prof. Karin BlakemoreJohns Hopkins University School of Medicine, Baltimore, MD, USA
Paediatric endocrinologist - Prof. Dr. med. Klaus Mohnike Otto-von-Guericke University Magdeburg, Magdeburg, Germany  
Paediatrician - Prof. Janet LegareUniversity of Wisconsin School of Medicine and Public Health, Madison, WI, USA
Patient advocate - Ms Carly KutnerFreehold, NJ, USA
This touchPODCAST is for HCPs only.This activity is funded by an unrestricted independent medical education grant from BioMarin Pharmaceutical Inc. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchendocrinologyime.org/mdt-diagnosis-monitoring-early-treatment-in- achondroplasia/

touchMDT for touchENDOCRINOLOGY
Listen to experts Prof. Janet Legare and Prof. Klaus Mohnike, plus patient advocate Carly Kutner, explore the importance of monitoring and early treatment initiation in achondroplasia to reduce the risk of paediatric complications
The multidisciplinary team and patient advocate:
Paediatrician - Prof. Janet LegareUniversity of Wisconsin School of Medicine and Public Health, Madison, WI, USA
Paediatric endocrinologist - Prof. Dr. med. Klaus Mohnike Otto-von-Guericke University Magdeburg, Magdeburg, Germany  
Patient advocate - Ms Carly KutnerFreehold, NJ, USA
This touchPODCAST is for HCPs only.This activity is funded by an unrestricted independent medical education grant from BioMarin Pharmaceutical Inc. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchendocrinologyime.org/mdt-diagnosis-monitoring-early-treatment-in- achondroplasia/

touchMDT for touchENDOCRINOLOGY
Listen to experts Prof. Janet Legare, Prof. Karin Blakemore, Prof. Klaus Mohnike and patient advocate Carly Kutner explore the importance of early recognition of achondroplasia in reducing the risk of paediatric complications.
The multidisciplinary team and patient advocate:
Paediatrician - Prof. Janet LegareUniversity of Wisconsin School of Medicine and Public Health, Madison, WI, USA
MFM specialist - Prof. Karin BlakemoreJohns Hopkins University School of Medicine, Baltimore, MD, USA
Paediatric endocrinologist - Prof. Dr. med. Klaus Mohnike Otto-von-Guericke University Magdeburg, Magdeburg, Germany  
Patient advocate - Ms Carly KutnerFreehold, NJ, USA
This touchPODCAST is for HCPs only.This activity is funded by an unrestricted independent medical education grant from BioMarin Pharmaceutical Inc. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchendocrinologyime.org/mdt-diagnosis-monitoring-early-treatment-in- achondroplasia/

touchMDT for touchENDOCRINOLOGY
Listen to key experts Prof. Klaus Mohnike, Prof. Karin Blakemore and Prof. Janet Legare discuss the multidisciplinary management of achondroplasia, including the importance of appropriate specialist referrals
The multidisciplinary team:
MFM specialist - Prof. Karin BlakemoreJohns Hopkins University School of Medicine, Baltimore, MD, USA
Paediatrician - Prof. Janet LegareUniversity of Wisconsin School of Medicine and Public Health, Madison, WI, USA
Paediatric endocrinologist - Prof. Dr. med. Klaus Mohnike Otto-von-Guericke University Magdeburg, Magdeburg, Germany  
This touchPODCAST is for HCPs only.This activity is funded by an unrestricted independent medical education grant from BioMarin Pharmaceutical Inc. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchendocrinologyime.org/mdt-diagnosis-monitoring-early-treatment-in- achondroplasia/

touchEXPERT OPINIONS for touchONCOLOGY
In this activity, Prof. Thomas Powles, an oncologist specializing in bladder cancer, provides an update on the latest developments in the treatment of advanced urothelial carcinoma, including the latest guideline recommendations, supporting clinical data and factors to support decision making in clinical practice.
The expert
Prof. Thomas Powles, Barts Cancer Centre, London, UK
This touchPODCAST is for HCPs outside of the UK and USA only.
This activity is funded by an independent medical education grant from Astellas Pharma Inc. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: 
https://touchoncologyime.org/advanced-urothelial-carcinoma-expert-guidance-to-navigate-an-evolving-therapeutic-landscape

touchEXPERT OPINIONS for touchONCOLOGY
A gynaecological oncologist considers the expanding role of molecular classification in endometrial cancer and provides an update on the use of immune checkpoint inhibitors to treat patients with advanced or recurrent disease, including key guideline recommendations, supporting data and considerations for clinical practice.
The expert
Prof. David Cibula, General University Hospital and Charles University, Prague, Czech Republic
This touchPODCAST is for HCPs outside of the UK only.This activity is funded by an independent medical education grant from Merck & Co, Inc.  This activity is jointly provided by USF Health and touchIME.For further information visit our website: 
https://touchoncologyime.org/immunotherapy-in-endometrial-cancer/